Valuation: genOway

Market Cap 21.58M 24.53M 20.4M 18.5M 34.75M 2.35B 34.95M 244M 94.34M 1.2B 92.1M 90.11M 3.86B P/E 2024 *
-
P/E 2025 -
Enterprise Value 28.29M 32.17M 26.75M 24.27M 45.57M 3.09B 45.84M 320M 124M 1.58B 121M 118M 5.06B EV / Sales 2024
1.36x
EV / Sales 2025 1.22x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day-0.85%
1 week-5.65%
Current month-5.65%
1 month-5.26%
3 months+1.30%
6 months-3.70%
Current year-13.65%
1 week 2.31
Extreme 2.31
2.5
1 month 2.31
Extreme 2.31
2.53
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.07
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
1/20/22 Buy

Chief Executive Officer

12,500 0.1376%
11/17/21 Sell

Chief Executive Officer

5,000 0.0553%
11/13/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%-5.65%-21.48%-43.20% 24.8M
+2.64%+6.45%+11.87%+38.40% 47.97B
+0.22%+0.40%+50.91%+37.06% 44.5B
-1.58%+4.66%+359.34%+614.38% 43.93B
+1.70%+0.36%+12.56%+99.27% 41.03B
+0.51%-0.61%+5.18%+46.87% 29.85B
-0.48%-1.32%+23.98%+150.01% 17.27B
+0.08%+9.03%+8.41% - 15.34B
+1.76%+0.85%+29.13%+48.42% 15.3B
+1.97%-3.17% - - 14.82B
Average +0.60%+0.91%+53.32%+123.90% 27B
Weighted average by Cap. +0.74%+1.89%+79.46%+163.77%

Financials

2024 2025
Net sales 25.84M 29.38M 24.44M 22.17M 41.63M 2.82B 41.87M 293M 113M 1.44B 110M 108M 4.63B 26.03M 29.6M 24.61M 22.33M 41.93M 2.84B 42.17M 295M 114M 1.45B 111M 109M 4.66B
Net income 1.83M 2.08M 1.73M 1.57M 2.95M 200M 2.97M 20.73M 8.01M 102M 7.82M 7.65M 328M 928K 1.05M 877K 796K 1.49M 101M 1.5M 10.5M 4.06M 51.67M 3.96M 3.87M 166M
Net Debt 623K 708K 589K 534K 1M 67.99M 1.01M 7.05M 2.72M 34.7M 2.66M 2.6M 111M 6.72M 7.64M 6.35M 5.76M 10.82M 733M 10.88M 76.06M 29.38M 374M 28.68M 28.06M 1.2B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-09-28 €2.340 -0.85% 9,640
26-09-25 €2.360 -1.67% 4,887
26-09-24 €2.400 0.00% 58,604
26-09-23 €2.400 -1.64% 5,522
26-09-22 €2.440 -1.61% 4,883
  1. Stock Market
  2. Stocks
  3. ALGEN Stock